Jerini AG - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Jerini AG. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Jerini AG. The Group's principal activity is discovery and development of novel peptide based drugs. The Group focus on the capitalization of the potential of peptidomimetic and small molecule substrates transformed by Group's novel drug discovery method to therapeutic drugs. The Group operates through two business segments Jerini Pharma and Peptide Technologies. The Jerini Pharma segment is engaged in the discovery and development of targeted therapeutics for hereditary angioedema, liver cirrhosis, cancer and inflammatory diseases. The Peptide Technologies segment serves the life science industry and research community by producing custom and catalogue peptides using its integrated array-based technology platforms.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report